Search Results 241-250 of 17394 for Toxicology

  1. Claudication - Doctors and departments - Mayo Clinic

    Too little blood flow to the legs and arms can cause pain, especially during exercise. Learn more about diagnosing and treating intermittent claudication.

  2. About - Risk Communications Program - Mayo Clinic Research

    Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...

  3. A Study to Evaluate Radiation Dermatitis Severity in Irradiated Skin protected By An Agent Versus Uncovered Skin - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Medical Research & Education - Mayo Clinic News Network

    There is a study of the fascinating interplay between the cumulative effects of external exposures on a person's body and genes. It is called exposomics.[.

  5. Metabolic Biotinylation - Virology, Vector and Vaccine Engineering: Michael A. Barry - Mayo Clinic Research

    Current vectors being engineered include adenovirus, adeno-associated virus, herpes virus and nonviral vectors. The goal of this project is to develop ...

  6. A Study Of Chemotherapy Selection For PM For Colorectal And Appendiceal Cancers - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Drugs and Supplements that Start with T - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “T” to learn about drug side effects, proper use and ...

  8. A Study to Evaluate if a Conversation Aid Will Help Patients and Clinicians in Discuss Diagnostic Testing - Mayo Clinic

    About this study. The purpose of this study is to determine whether a diagnostic reconciliation conversation aid can assist a shared decision making ...

  9. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    This randomized Phase III, multicenter, open-label study is designed to evaluate the safety and efficacy of atezolizumab in combination with carboplatin + nab- ...

  10. Publications - Eva M. Carmona Porquera, M.D., Ph.D. - Mayo Clinic

    2022 Jun 01; 28(4):217-222. Epub 2022 Mar 22. View PubMed; Kottom TJ, Schaefbauer K, Carmona EM, Yi ES, Limper AH. Preclinical and Toxicology Studies of BRD5529 ...